Related references
Note: Only part of the references are listed.Suppression of angiogenesis and tumor growth by recombinant T4 phages displaying extracellular domain of vascular endothelial growth factor receptor 2
Shuguang Zuo et al.
ARCHIVES OF VIROLOGY (2019)
Phage display screening of therapeutic peptide for cancer targeting and therapy
Phei Er Saw et al.
PROTEIN & CELL (2019)
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies
Rossella Sartorius et al.
PHARMACEUTICS (2019)
The fascinating biology behind phage display: filamentous phage assembly
Belinda Loh et al.
MOLECULAR MICROBIOLOGY (2019)
Phage Display: An Overview in Context to Drug Discovery
Selena Mimmi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet?
Oliver S. Thomas et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice
Atefeh Razazan et al.
SCIENTIFIC REPORTS (2019)
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response
Atefeh Arab et al.
IMMUNOLOGIC RESEARCH (2018)
Immunogenicity and antitumor activity of the superlytic lambda F7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
Nastaran Barati et al.
CANCER LETTERS (2018)
Nanoparticles in Cancer Treatment: Opportunities and Obstacles
Rajendra Awasthi et al.
CURRENT DRUG TARGETS (2018)
Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses
Girja S. Shukla et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Contribution of the Immune Response to Phage Therapy
Oleg Krut et al.
JOURNAL OF IMMUNOLOGY (2018)
Biotechnological applications of bacteriophages: State of the art
Liliam K. Harada et al.
MICROBIOLOGICAL RESEARCH (2018)
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer
Caterina Bartolacci et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
Yijuan Zhang et al.
ACS NANO (2017)
Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells
Tatsuya Fukuta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Nanoparticles and innate immunity: new perspectives on host defence
Diana Boraschi et al.
SEMINARS IN IMMUNOLOGY (2017)
Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
Zhigang Ju et al.
DRUG DELIVERY (2017)
Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos
Mahdi Karimi et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
Shahil Amin et al.
BMC CANCER (2016)
Ligand-targeted theranostic nanomedicines against cancer
Virginia J. Yao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes
Andrey S. Dobroff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas
Tracey L. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Asymmetric cryo-EM reconstruction of phage MS2 reveals genome structure in situ
Roman I. Koning et al.
NATURE COMMUNICATIONS (2016)
Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma
Le Chang et al.
ONCOTARGET (2016)
Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons
Dan Zhang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter
Ana R. Rama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors
Teerapong Yata et al.
MOLECULAR CANCER (2015)
Phage display: development of nanocarriers for targeted drug delivery to the brain
Babak Bakhshinejad et al.
NEURAL REGENERATION RESEARCH (2015)
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
Mikhail O. Durymanov et al.
THERANOSTICS (2015)
Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery
Lorena Sanchez-Sanchez et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
T4 bacteriophage as a phage display platform
Mariam Gamkrelidze et al.
ARCHIVES OF MICROBIOLOGY (2014)
A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model
Kosuke Higashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein
Tao Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Therapeutic and Prophylactic Applications of Bacteriophage Components in Modern Medicine
Sankar Adhya et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids
Brian A. Cohen et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2013)
Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model
Tim Roehnisch et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage
Justyna M. Przystal et al.
MOLECULAR ONCOLOGY (2013)
Targeted Expression of Suicide Gene by Tissue-Specific Promoter and MicroRNA Regulation for Cancer Gene Therapy
Ravikanth Danda et al.
PLOS ONE (2013)
A Novel Heavy Domain Antibody Library with Functionally Optimized Complementarity Determining Regions
Ole Aalund Mandrup et al.
PLOS ONE (2013)
Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs
Yi Shu et al.
RNA (2013)
Bacteriophage Bionanowire as a Carrier for Both Cancer-Targeting Peptides and Photosensitizers and its use in Selective Cancer Cell Killing by Photodynamic Therapy
Naveen Gandra et al.
SMALL (2013)
Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system
Olusegun A. Fagbohun et al.
JOURNAL OF NANOBIOTECHNOLOGY (2013)
Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD)
Yuan Qiu et al.
CANCER LETTERS (2012)
Infective and inactivated filamentous phage as carriers for immunogenic peptides
Tatiana I. Samoylova et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor Regression
Azadeh Kia et al.
MOLECULAR CANCER THERAPEUTICS (2012)
M13 Phage-Functionalized Single-Walled Carbon Nanotubes As Nanoprobes for Second Near-Infrared Window Fluorescence Imaging of Targeted Tumors
Hyunjung Yi et al.
NANO LETTERS (2012)
Induction of Protective Anti-CTL Epitope Responses against HER-2-Positive Breast Cancer Based on Multivalent T7 Phage Nanoparticles
Somayeh Pouyanfard et al.
PLOS ONE (2012)
Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine
Brad S. Thomas et al.
VACCINE (2012)
Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
Azam Bolhassani
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants
Rossella Sartorius et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Protection of Mice by a lambda-Based Therapeutic Vaccine against Cancer Associated with Human Papillomavirus Type 16
Amir Ghaemi et al.
INTERVIROLOGY (2011)
Molecular Rearrangements Involved in the Capsid Shell Maturation of Bacteriophage
Alina Ionel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Application of Phi29 Motor pRNA for Targeted Therapeutic Delivery of siRNA Silencing Metallothionein-IIA and Survivin in Ovarian Cancers
Pheruza Tarapore et al.
MOLECULAR THERAPY (2011)
DNA Libraries for the Construction of Phage Libraries: Statistical and Structural Requirements and Synthetic Methods
Thomas Lindner et al.
MOLECULES (2011)
Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells
Rick K. Huang et al.
NANOMEDICINE (2011)
Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine
Shunxiang Ren et al.
VACCINE (2011)
Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide
Bing Du et al.
MOLECULAR CANCER RESEARCH (2010)
Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein
Tao Wang et al.
NANOMEDICINE (2010)
Engineering filamentous phage carriers to improve focusing of antibody responses against peptides
Nienke E. van Houten et al.
VACCINE (2010)
Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface
Shun-xiang Ren et al.
ACTA PHARMACOLOGICA SINICA (2009)
Targeting of Tumor Blood Vessels: A Phage-Displayed Tumor-Homing Peptide Specifically Binds to Matrix Metalloproteinase-2-Processed Collagen IV and Blocks Angiogenesis In vivo
Jan Mueller et al.
MOLECULAR CANCER RESEARCH (2009)
Inhibition of cell growth and invasion by epidermal growth factor-targeted phagemid particles carrying siRNA against focal adhesion kinase in the presence of hydroxycamptothecin
Xiu-Mei Cai et al.
BMC BIOTECHNOLOGY (2008)
Targeted filamentous bacteriophages as therapeutic agents
Iftach Yacoby et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses
Rossella Sartorius et al.
JOURNAL OF IMMUNOLOGY (2008)
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging
Amin Hajitou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Patrick J. Perik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide
N. E. van Houten et al.
VACCINE (2006)
A hybrid vector for ligand-directed tumor targeting and molecular imaging
A Hajitou et al.
CELL (2006)
Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I
AM Cuesta et al.
IMMUNOLOGY (2006)
Thermostability of landscape phage probes
JR Brigati et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA
SC Guo et al.
HUMAN GENE THERAPY (2005)
Genetic immunisation against hepatitis B using whole bacteriophage λ particles
JB March et al.
VACCINE (2004)
Bacteriophage-mediated nucleic acid immunisation
JR Clark et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage -: art. no. 78
E Pavoni et al.
BMC CANCER (2004)
Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle
CD Jepson et al.
VACCINE (2004)
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments
M Gaubin et al.
DNA AND CELL BIOLOGY (2003)
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
M Shadidi et al.
FASEB JOURNAL (2002)
Selection of tumor-specific internalizing human antibodies from phage libraries
MA Poul et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)